Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer-Reference-Cited by-同舟云学术

Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer

Published:2015-06-08 Issue:27 Volume:6 Page:23582-23593
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cheng Ningning¹,Cai Weijing¹,Ren Shengxiang¹,Li Xuefei²,Wang Qi¹,Pan Hui¹,Zhao Mingchuan¹,Li Jiayu¹,Zhang Yishi¹,Zhao Chao²,Chen Xiaoxia¹,Fei Ke³,Zhou Caicun¹,Hirsch Fred R.⁴

Affiliation:

1. Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, P. R. China

2. Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, P. R. China

3. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Tongji University Medical School Cancer Institute, Shanghai, P. R. China

4. Department of Medical and Pathology, University of Colorado Cancer Center, Aurora, Colorado, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical role of the long non-coding RNAs (lncRNAs) in radiotherapy (RT)-resistance of gastrointestinal (GI) cancer: Is there a way to defeat this resistance?;Pathology - Research and Practice;2024-06

2. Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths;Cell Biochemistry and Biophysics;2024-05-28

3. Silencing of lncRNA UCA1 Reverses Doxorubicin Resistance of Breast Cancer Through Inhibiting PI3K/AKT/mTOR Signaling Pathway;ChemistrySelect;2024-05-24

4. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions;Cancer Cell International;2024-01-10

5. From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer;Pathology - Research and Practice;2024-01